-
DiR Imaging for Nanomedicine Design
2026-09-25
DiR (DiIC 18 (7)) provides near-infrared membrane labeling for cell tracking and tissue imaging. This article explains how to use its signal thoughtfully when investigating protease-responsive nanomedicine, including what fluorescence can—and cannot—show about delivery and biological response.
-
Hydroxytyrosol: Mechanisms and Research Use
2026-09-25
Hydroxytyrosol, or 4-(2-hydroxyethyl)benzene-1,2-diol, is an olive-derived phenolic antioxidant bioactive compound used in research on oxidative stress modulation and inflammation. Product specifications support in vitro use, but the supplied chronic kidney disease reference does not establish hydroxytyrosol as a treatment or demonstrate kidney-specific efficacy.
-
Optimizing Functional Platelet Production from hiPSCs
2026-09-24
A 2026 study combines higher embryoid-body input, human platelet lysate, small-molecule substitutions and enhanced megakaryocyte maturation to improve platelet differentiation from human induced pluripotent stem cells. The optimized workflow reports a 19-day process, functional platelet activity in vitro and lower production costs, while its results do not establish SU6656 as a driver of the improved yield.
-
Cefepime (BMY-28142) in Resistance Models
2026-09-24
Use Cefepime (BMY-28142) to measure a direct antibacterial response while mapping how carbapenemase genes and mobile plasmids shape that response. This workflow links susceptibility testing to resistance-transmission experiments, with practical controls for fresh solutions, assay reproducibility, and neurotoxicity-aware CNS research.
-
EdU Cell Proliferation Kit for S-Phase Studies
2026-09-23
Translate changes in DNA synthesis into a non-radioactive, plate-based readout for rheumatoid arthritis fibroblast-like synoviocyte research and other proliferation studies. This guide connects ARL4C biology to practical assay design while emphasizing controls that separate S-phase entry from toxicity and changes in cell number.
-
Influenza Hemagglutinin (HA) Peptide in EV Studies
2026-09-23
Explore how the Influenza Hemagglutinin (HA) Peptide can turn HA-tagged protein recovery into a precise assay-design variable for exosome and extracellular-vesicle research. This article connects competitive elution, tag accessibility, and the RAB31-dependent ESCRT-independent pathway while clearly separating established evidence from workflow recommendations.
-
SB-3CT: Causal Assays for MMP-9 and ECM
2026-09-22
SB-3CT is a selective gelatinase inhibitor for testing how MMP-2 and MMP-9 reshape extracellular matrix biology. This article develops a causal assay framework linking Adamtsl3–MMP9–perineuronal-net findings to tumor metastasis research, angiogenesis inhibition, and neuroprotection in cerebral ischemia.
-
Novel FLCN Mutations and mRNA Rescue in BHD
2026-09-22
This 2026 study identifies the FLCN p.Q44* mutation and provides functional and co-segregation evidence that p.W376R is pathogenic in two Chinese families with Birt-Hogg-Dubé syndrome. Its cell-based rescue experiments also offer preliminary support for FLCN mRNA supplementation as a protein-replacement strategy, although the approach remains preclinical.
-
Influenza Hemagglutinin (HA) Peptide Workflows
2026-09-21
Use the Influenza Hemagglutinin (HA) Peptide as a practical competitive-elution reagent for HA-tagged protein detection, immunoprecipitation, and interaction studies. Its high purity, broad solubility, and compatibility with Anti-HA Magnetic Beads support workflows that preserve native complexes while enabling targeted recovery.
-
EZ Cap™ Cre mRNA (m1Ψ) Workflow Guide
2026-09-21
Build transient, quantifiable Cre-lox assays with a Cap 1, m1Ψ-modified, polyadenylated transcript designed for efficient translation and reduced innate immune activation. This guide connects practical delivery workflows with extrahepatic mRNA-platform development while separating validated findings from forward-looking assay applications.
-
Cy5 TSA Fluorescence System Kit for Astrocyte Maps
2026-09-20
The Cy5 TSA Fluorescence System Kit converts transcriptomic astrocyte hypotheses into high-sensitivity spatial assays. Learn how HRP-driven tyramide deposition supports immunohistochemistry, immunocytochemistry, and in situ hybridization while preserving regional and developmental context.
-
HyperFluor 488 Goat Anti-Mouse IgG Guide
2026-09-19
HyperFluor 488 Goat Anti-Mouse IgG is a fluorescently labeled secondary antibody for detecting mouse IgG in immunofluorescence, flow cytometry, and western blotting. Its H+L binding profile supports signal amplification, while the K1204 formulation provides defined concentration, buffer, and storage conditions.
-
EZ Cap™ Cre mRNA (m1Ψ) for Gene Editing
2026-09-18
EZ Cap™ Cre mRNA (m1Ψ) is a Cap 1, polyadenylated Cre recombinase mRNA designed for transient loxP recombination studies. Its m1Ψ modification, RNase-controlled handling, and low-temperature storage support gene editing mRNA workflows in vitro and in vivo.
-
EPZ5676: From DOT1L Blockade to Immune Signaling
2026-09-18
Explore how EPZ5676, a highly selective DOT1L inhibitor, connects H3K79 methylation inhibition with leukemia biology and emerging innate immune mechanisms in multiple myeloma. This article translates recent evidence into a decision framework for mechanistic assays, combination studies, and rigorous interpretation.
-
Wnt–BMP Patterning in Ptychodera flava
2026-09-17
Le Petillon and colleagues define how Wnt and BMP signals coordinate anterior neuroectoderm formation in the indirect-developing hemichordate Ptychodera flava. The study identifies posterior Wnt activity as an anterior-restricting cue and reveals a biphasic role for BMP, providing a useful comparative framework for deuterostome axis and neural patterning studies.